Skip to content

STIM

Neuronetics, Inc.

NASDAQ · USHealthcareMedical - Diagnostics & Research
$2.02+24.69%

Price as of Jul 20, 2026

STIM capital

Neuronetics, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
6.44x
Net debt / equity
5.44x
Debt / assets
0.68x
Debt / EBITDA
-3.32x
Net debt / EBITDA
-2.81x

Liquidity & coverage

Current ratio
1.67x
Quick ratio
1.50x
Cash ratio
0.47x
Interest coverage
-3.50x
EBITDA / interest
-3.05x
Working capital
$18.9M

Cash & dividend

FCF / debt
-0.16x
Cash flow / debt
-0.15x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.